| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | SVP, Regulatory & QA | Common Stock | 162,672 | $426,201 | $2.62 | 28 Feb 2024 | Direct |
| LEXICON PHARMACEUTICALS, INC. | SVP, Regulatory & QA | Restricted Stock Units | 65,513 | $171,644 | $2.62 | 28 Feb 2024 | Direct |
| LEXICON PHARMACEUTICALS, INC. | SVP, Regulatory & QA | Stock Option (Right to Buy) | 203,810 | 08 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | 28 Feb 2024 | 7 | -$63,805 | 4 | SVP, Regulatory & QA | 29 Feb 2024, 16:29 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 08 Feb 2024 | 2 | $0 | 4 | SVP, Regulatory & QA | 12 Feb 2024, 16:15 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 28 Feb 2023 | 7 | -$41,486 | 4 | SVP, Regulatory & QA | 01 Mar 2023, 15:51 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 09 Feb 2023 | 2 | $0 | 4 | SVP, Regulatory & QA | 13 Feb 2023, 16:00 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 28 Feb 2022 | 7 | -$37,737 | 4 | SVP, Regulatory & QA | 28 Feb 2022, 18:15 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 10 Feb 2022 | 2 | $0 | 4 | SVP, Regulatory & QA | 14 Feb 2022, 15:06 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 01 Oct 2021 | 0 | $0 | 3 | SVP, Regulatory & QA | 01 Oct 2021, 16:05 |